Foundation Venture Capital Group Commits $1 Million to Hackensack Meridian Health’s First Spin-out Company, EValuate Diagnostics   

Foundation Venture Capital Group Commits $1 Million to Hackensack Meridian Health’s First Spin-out Company, EValuate Diagnostics

February 08, 2024

Oliver Loudig

The company, based on science from the Hackensack Meridian Center for Discovery and Innovation, promises to capture biomarkers for early detection of disease

EValuate Diagnostics, the first spin-out company from the Hackensack Meridian Health Research Institute and its Office of Innovation and Commercialization, is the newest addition to Foundation Venture Capital Group’s (FVCG’s) portfolio.

Read more

We use cookies to improve your site experience. By using this site,
you agree to our Terms & Conditions. Also, please read our Privacy Policy. Accept All CookiesLearn More
X